http://www.fpnotebook.com/
Venlafaxine
Aka: Venlafaxine, Effexor, Desvenlafaxine, Pristiq
- Indications
- Major Depression including refractory cases
- Considered to be second-line agent
- Generalized Anxiety Disorder
- Mechanism
- Similar activity as Tricyclic Antidepressants
- Serotonin Norepinephrine Reuptake Inhibitor
- Selective Serotonin Reuptake Inhibitor (<150 mg/day)
- Norepinephrine Reuptake Inhibitor (>150 mg/day)
- Minimally inhibits Dopamine uptake
- Pharmacokinetics
- Half life: 5 to 11 hours
- Background
- Cost: $60 per month
- Preparations
- Effexor Tablets (scored): 25, 37.5, 75, 100 mg
- Effexor XR Capsules: 37.5, 75, 150 mg
- Pristiq (Desvenlafaxine)
- Active metabolite of Effexor XR
- No added benefit over Effexor XR and with possibly more adverse effects
- Reference
- (2008) Prescriber's Letter 15(5): 28
- Dosing: Effexor
- Start: 25 mg PO tid
- Effective dose: 150-225 mg per day divided bid to tid
- Maximum dose: 375 mg per day
- Disadvantages: More adverse effects than Effexor XR
- Advantages: May be dosed once daily since metabolites offer similar duration to Effexor XR
- Dosing: Effexor XR (extended release)
- Start: 37.5 to 75 mg PO qd
- Maximum: 225 mg PO qd
- Precautions: Prominent Withdrawal symptoms
- See also Antidepressant Withdrawal
- Dizziness, irritability and Insomnia
- Symptoms start 3 days after stopping medication
- Effexor taper schedule
- Reduce dose 25 mg/day every 5-7 days
- Taper to 25-50 mg/day before stopping
- Effexor XR taper schedule
- Reduce dose 37.5 to 75 mg per day every 7 days
- Taper to 37.5 mg/day before stopping
- Adverse Effects (higher with regular release Effexor)
- Anticholinergic (less than Tricyclic Antidepressants)
- Dizziness
- Somnolence
- Dry Mouth
- Nausea or Vomiting
- May be severe and limit dosing
- Start therapy at 25 mg per day
- Increased Blood Pressure
- Only seen with total daily doses 300 mg or higher
- Less Sexual Dysfunction than Prozac, Zoloft, Paxil
- Sexual dysfunction in 10-15% of cases
- Similar to Luvox and Celexa
- See Antidepressant Induced Sexual Dysfunction
- More stimulating (anxiogenic) than sedating
- Agitation or Insomnia may occur
- Decreased appetite and Weight loss may occur
- Drug Interactions
- Minimal Cytochrome P450 interactions
- References
- (1997) Am J Psych 154:1760
- Sundberg (1995) Depression Primary Care, PGM, p. 45-57